There hasn't been any recent discussion on Goldman's corporate derivatives group. According to the new CEO, "the firm is particularly pursuing revenues in corporate derivatives. It currently ranks fourth in this market, and therefore has an opportunity to grow".
From reading online, the corporate derivatives group sits in the Financing Arm of the Investment Banking Division, but appears to be more of a hybrid between IB & S&T. Does anyone have any up-to-date insight onto job responsibilities/overall quality of experience/exit ops in relation to more traditional IB routes, especially at the analyst/junior banker level (e.g. compared to Classic banking or even LevFin in the financing group)?